119 related articles for article (PubMed ID: 28579269)
1. IRF2-INPP4B axis participates in the development of acute myeloid leukemia by regulating cell growth and survival.
Zhang F; Zhu J; Li J; Zhu F; Zhang P
Gene; 2017 Sep; 627():9-14. PubMed ID: 28579269
[TBL] [Abstract][Full Text] [Related]
2. IRF2-INPP4B-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells.
Zhang F; Li J; Zhu J; Liu L; Zhu K; Cheng S; Lv R; Zhang P
Biol Res; 2019 Mar; 52(1):11. PubMed ID: 30876449
[TBL] [Abstract][Full Text] [Related]
3. IRF2-INPP4B axis inhibits apoptosis of acute myeloid leukaemia cells via regulating T helper 1/2 cell differentiation.
Zhang F; Zhu K; Liu L; Zhu J; Li J; Zhang P; Hu Z; Yuan Y
Cell Biochem Funct; 2020 Jul; 38(5):582-590. PubMed ID: 32115737
[TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B.
Zhang F; Lu Y; Wang M; Zhu J; Li J; Zhang P; Yuan Y; Zhu F
Mol Cell Probes; 2020 Jun; 51():101513. PubMed ID: 31968218
[TBL] [Abstract][Full Text] [Related]
5. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
6. INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.
Dzneladze I; He R; Woolley JF; Son MH; Sharobim MH; Greenberg SA; Gabra M; Langlois C; Rashid A; Hakem A; Ibrahimova N; Arruda A; Löwenberg B; Valk PJ; Minden MD; Salmena L
Leukemia; 2015 Jul; 29(7):1485-95. PubMed ID: 25736236
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA SENCR facilitates the progression of acute myeloid leukemia through the miR-4731-5p/IRF2 pathway.
Han C; Qi Y; She Y; Zhang M; Xie H; Zhang J; Zhao Z; Peng C; Liu Y; Lin Y; Wang J; Zeng D
Pathol Res Pract; 2023 May; 245():154483. PubMed ID: 37120908
[TBL] [Abstract][Full Text] [Related]
8. The IRF9-SIRT1-P53 axis is involved in the growth of human acute myeloid leukemia.
Tian WL; Guo R; Wang F; Jiang ZX; Tang P; Huang YM; Sun L
Exp Cell Res; 2018 Apr; 365(2):185-193. PubMed ID: 29501566
[TBL] [Abstract][Full Text] [Related]
9. IRF3 is involved in human acute myeloid leukemia through regulating the expression of miR-155.
Tian WL; Jiang ZX; Wang F; Guo R; Tang P; Huang YM; Sun L
Biochem Biophys Res Commun; 2016 Sep; 478(3):1130-5. PubMed ID: 27530922
[TBL] [Abstract][Full Text] [Related]
10. Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML.
Rijal S; Fleming S; Cummings N; Rynkiewicz NK; Ooms LM; Nguyen NY; Teh TC; Avery S; McManus JF; Papenfuss AT; McLean C; Guthridge MA; Mitchell CA; Wei AH
Blood; 2015 Apr; 125(18):2815-24. PubMed ID: 25736313
[TBL] [Abstract][Full Text] [Related]
11. SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.
Dzneladze I; Woolley JF; Rossell C; Han Y; Rashid A; Jain M; Reimand J; Minden MD; Salmena L
PLoS One; 2018; 13(2):e0191510. PubMed ID: 29415082
[TBL] [Abstract][Full Text] [Related]
12. INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.
Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Cao L; Hu X; Zhao J; Li Y
Tumour Biol; 2016 Sep; 37(9):12513-12523. PubMed ID: 27342972
[TBL] [Abstract][Full Text] [Related]
13. SHIP1 is targeted by miR-155 in acute myeloid leukemia.
Xue H; Hua LM; Guo M; Luo JM
Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cell-Derived Exosomal miRNA-222-3p Increases Th1/Th2 Ratio and Promotes Apoptosis of Acute Myeloid Leukemia Cells.
Yuan Y; Tan S; Wang H; Zhu J; Li J; Zhang P; Wang M; Zhang F
Anal Cell Pathol (Amst); 2023; 2023():4024887. PubMed ID: 37621743
[TBL] [Abstract][Full Text] [Related]
15. SPG6 supports development of acute myeloid leukemia by regulating BMPR2-Smad-Bcl-2/Bcl-xl signaling.
Chen J; Li C; Zhan R; Yin Y
Biochem Biophys Res Commun; 2018 Jun; 501(1):220-225. PubMed ID: 29715457
[TBL] [Abstract][Full Text] [Related]
16. siRNA targeting the IRF2 transcription factor inhibits leukaemic cell growth.
Choo A; Palladinetti P; Holmes T; Basu S; Shen S; Lock RB; O'Brien TA; Symonds G; Dolnikov A
Int J Oncol; 2008 Jul; 33(1):175-83. PubMed ID: 18575764
[TBL] [Abstract][Full Text] [Related]
17. p70S6 kinase is a target of the novel proteasome inhibitor 3,3'-diamino-4'-methoxyflavone during apoptosis in human myeloid tumor cells.
Piedfer M; Bouchet S; Tang R; Billard C; Dauzonne D; Bauvois B
Biochim Biophys Acta; 2013 Jun; 1833(6):1316-28. PubMed ID: 23481040
[TBL] [Abstract][Full Text] [Related]
18. INPP4B is an oncogenic regulator in human colon cancer.
Guo ST; Chi MN; Yang RH; Guo XY; Zan LK; Wang CY; Xi YF; Jin L; Croft A; Tseng HY; Yan XG; Farrelly M; Wang FH; Lai F; Wang JF; Li YP; Ackland S; Scott R; Agoulnik IU; Hondermarck H; Thorne RF; Liu T; Zhang XD; Jiang CC
Oncogene; 2016 Jun; 35(23):3049-61. PubMed ID: 26411369
[TBL] [Abstract][Full Text] [Related]
19. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
[TBL] [Abstract][Full Text] [Related]
20. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
